Tunney MM[Author] - Search Results

Year	Number of Results
1996	2
1997	2
1998	3
1999	3
2002	1
2003	1
2004	2
2005	3
2006	3
2007	8
2008	8
2009	5
2010	4
2011	6
2012	4
2013	10
2014	6
2015	8
2016	9
2017	10
2018	10
2019	10
2020	9
2021	6
2022	10
2023	3
2024	3

1

Fusobacterium nucleatum: a novel immune modulator in breast cancer?

Little A, Tangney M, Tunney MM, Buckley NE. Little A, et al. Among authors: tunney mm. Expert Rev Mol Med. 2023 Apr 3;25:e15. doi: 10.1017/erm.2023.9. Expert Rev Mol Med. 2023. PMID: 37009688 Free PMC article. Review.

2

Antifungal photodynamic therapy.

Donnelly RF, McCarron PA, Tunney MM. Donnelly RF, et al. Among authors: tunney mm. Microbiol Res. 2008;163(1):1-12. doi: 10.1016/j.micres.2007.08.001. Epub 2007 Nov 26. Microbiol Res. 2008. PMID: 18037279 Free article. Review.

3

Response.

O'Neill K, Elborn JS, Tunney MM, Bradley JM. O'Neill K, et al. Among authors: tunney mm. Chest. 2016 Dec;150(6):1413-1414. doi: 10.1016/j.chest.2016.09.037. Chest. 2016. PMID: 27938757 No abstract available.

4

The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis?

Héry-Arnaud G, Boutin S, Cuthbertson L, Elborn SJ, Tunney MM. Héry-Arnaud G, et al. Among authors: tunney mm. J Cyst Fibros. 2019 Jan;18(1):13-21. doi: 10.1016/j.jcf.2018.11.003. Epub 2018 Nov 25. J Cyst Fibros. 2019. PMID: 30487080 Free article. Review.

5

Establishing Antimicrobial Susceptibility Testing Methods and Clinical Breakpoints for Inhaled Antibiotic Therapy.

Ekkelenkamp MB, Díez-Aguilar M, Tunney MM, Elborn JS, Fluit AC, Cantón R. Ekkelenkamp MB, et al. Among authors: tunney mm. Open Forum Infect Dis. 2022 Feb 14;9(4):ofac082. doi: 10.1093/ofid/ofac082. eCollection 2022 Apr. Open Forum Infect Dis. 2022. PMID: 35265731 Free PMC article. Review.

6

The role of anaerobic bacteria in the cystic fibrosis airway.

Sherrard LJ, Bell SC, Tunney MM. Sherrard LJ, et al. Among authors: tunney mm. Curr Opin Pulm Med. 2016 Nov;22(6):637-43. doi: 10.1097/MCP.0000000000000299. Curr Opin Pulm Med. 2016. PMID: 27455453 Review.

7

Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist.

Tunney MM, Wark P. Tunney MM, et al. Eur Respir J. 2023 Aug 3;62(2):2301008. doi: 10.1183/13993003.01008-2023. Print 2023 Aug. Eur Respir J. 2023. PMID: 37536727 No abstract available.

8

Multi-Omics Approaches: The Key to Improving Respiratory Health in People With Cystic Fibrosis?

Lee AJ, Einarsson GG, Gilpin DF, Tunney MM. Lee AJ, et al. Among authors: tunney mm. Front Pharmacol. 2020 Sep 3;11:569821. doi: 10.3389/fphar.2020.569821. eCollection 2020. Front Pharmacol. 2020. PMID: 33013411 Free PMC article. Review.

9

R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease.

Rigauts C, Aizawa J, Taylor SL, Rogers GB, Govaerts M, Cos P, Ostyn L, Sims S, Vandeplassche E, Sze M, Dondelinger Y, Vereecke L, Van Acker H, Simpson JL, Burr L, Willems A, Tunney MM, Cigana C, Bragonzi A, Coenye T, Crabbé A. Rigauts C, et al. Among authors: tunney mm. Eur Respir J. 2022 May 5;59(5):2101293. doi: 10.1183/13993003.01293-2021. Print 2022 May. Eur Respir J. 2022. PMID: 34588194 Free PMC article.

10

Macrolides and bronchiectasis: clinical benefit with a resistance price.

Elborn JS, Tunney MM. Elborn JS, et al. Among authors: tunney mm. JAMA. 2013 Mar 27;309(12):1295-6. doi: 10.1001/jama.2013.2780. JAMA. 2013. PMID: 23532247 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

132 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year